For US Healthcare Professionals Only
Order Now
NIOX® Customer Experience
1-866-275-6469, Option 2
Monday-Friday, 8AM-7PM ET

Experience the Impact With NIOX VERO®

NIOX VERO with 55 ppb measurement

Routine FeNO Monitoring to aid in treatment optimization

Only NIOX VERO gives you an objective and accurate measurement of airway inflammation.1

  • Establish the patient's baseline and personal best FeNO level2,3
  • Assess adherence to ICS treatment4,5
  • Optimize the use of ICS and adjust accordingly4,6
  • Aids in diagnosis and helps to identify patients who may benefit from biologics7
  • To date, over 20 million tests have been performed using a NIOX device8

An accurate FeNO result in a single measurement with results in approximately

1 minute

NIOX-Guided Treatment Significantly Reduced Exacerbation Rates4,9

In Children

50% reduction chart

*An exacerbation was defined as an episode of progressive increased shortness of breath, coughing, wheezing, or chest tightness, or a combination of these symptoms.9

In Adults

46% reduction chart

Moderate exacerbations were defined as deterioration in symptoms with the need to step up controller treatment for at least 2 days, with or without a concomitant clinic visit or contact. Severe exacerbations were defined as worsening in asthma that necessitated a course of oral corticosteroids.4

References: 1. Spahn JD, Malka J, Szefler SJ. Current application of exhaled nitric oxide in clinical practice. J Allergy Clin Immunol. 2016; 138:1296-1298. 2. Smith AD, Cowan JO, Taylor RD. Exhaled nitric oxide levels in asthma: Personal best versus reference values. J Allergy Clin Immunol. 2009 Oct;124(4):714-8. 3. Dweik RA, Boggs PB, Erzurum SC, et al; on behalf of the American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-615. 4. Syk J, Malinovschi A, Johansson G, et al. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial. J Allergy Clin Immunol Pract. 2013;1(6):639-648. 5. Beck-Ripp J, Griese M, Arenz S, Köring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J. 2002;19(6):1015-1019. 6. Smith AD, Cowan JO, Brassett KP, Herbison P, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352(21):2163-2173. 7. Darveaux J, Busse WW. Biologics in asthma—the next step towards personalized treatment. J Allergy Clin Immunol Pract. 2015;3(2):152-161. 8. Data on file. Circassia Ltd May 2019. 9. Peirsman EJ, Carvelli TJ, Hage PY, et al. Exhaled nitric oxide in childhood allergic asthma management: a randomised controlled trial. Pediatr Pulmonol. 2014;49(7):624-631.